Top Page
China BlueChemical
(OTC:3983)
China BlueChemical (3983) vs. iShares MSCI Hong Kong ETF (EWH)
China BlueChemical Business Overview & Revenue Model
China BlueChemical Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 11.95B | 12.99B | 14.28B | 13.40B | 10.42B |
| Gross Profit | 1.70B | 2.06B | 2.54B | 2.94B | 1.33B |
| EBITDA | 1.55B | 3.33B | 2.35B | 2.76B | 1.32B |
| Net Income | 1.07B | 2.38B | 1.64B | 1.50B | 745.49M |
Balance Sheet | |||||
| Total Assets | 24.08B | 24.32B | 23.50B | 21.43B | 20.75B |
| Cash, Cash Equivalents and Short-Term Investments | 13.51B | 13.74B | 13.03B | 11.46B | 10.17B |
| Total Debt | 2.12B | 2.02B | 2.08B | 1.05B | 1.98B |
| Total Liabilities | 4.57B | 4.91B | 5.72B | 4.52B | 5.12B |
| Stockholders Equity | 18.41B | 18.30B | 16.75B | 15.83B | 14.70B |
Cash Flow | |||||
| Free Cash Flow | 918.02M | 800.48M | 806.70M | 1.88B | 890.36M |
| Operating Cash Flow | 1.52B | 1.54B | 2.14B | 2.94B | 1.26B |
| Investing Cash Flow | -379.00M | -691.13M | -2.35B | -3.66B | 1.11B |
| Financing Cash Flow | -1.06B | -784.06M | 65.37M | -1.37B | -415.86M |
China BlueChemical Technical Analysis
China BlueChemical Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$9.37B | 5.99 | 16.29% | 3.76% | 0.82% | 2.99% | |
73 Outperform | HK$9.48B | 7.92 | 10.19% | 4.15% | -0.34% | 64.10% | |
73 Outperform | $10.70B | 9.68 | 5.60% | 5.67% | -8.24% | -24.53% | |
53 Neutral | HK$2.13B | -57.77 | 0.59% | ― | -23.46% | -126.64% | |
42 Neutral | HK$13.85B | -4.06 | ― | ― | -24.68% | -51.76% | |
38 Underperform | HK$896.24M | -24.71 | -125.52% | ― | -5.79% | -129.73% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
China BlueChemical Corporate Events
China BlueChemical Ltd. has announced a board meeting scheduled for August 18-19, 2025, to review and approve the interim results for the first half of the year ending June 30, 2025. This meeting is crucial for stakeholders as it will provide insights into the company’s financial performance and strategic direction for the upcoming months.
China BlueChemical Ltd. has announced an extraordinary general meeting (EGM) scheduled for August 18, 2025, to discuss significant changes in its corporate governance structure. The meeting will focus on amending the company’s articles of association and the cancellation of its supervisory committee, which may impact the company’s operational framework and governance.
China BlueChemical has entered into a series of structured deposit agreements with the Bank of China (BOC) Hainan Branch, totaling RMB850 million. These transactions, which involve self-owned funds, are classified as discloseable under Hong Kong Listing Rules due to their aggregated transaction amounts exceeding 5% of applicable percentage ratios. This strategic financial maneuver is expected to enhance the company’s liquidity management while adhering to regulatory requirements.
China BlueChemical, a joint stock limited company incorporated in China, has entered into two structured deposit agreements with ICBC Hainan Branch, subscribing to products worth RMB400 million and RMB300 million respectively. These transactions, which involve self-owned funds, are classified as discloseable under Hong Kong Listing Rules due to the aggregated transaction amounts exceeding certain percentage thresholds, necessitating notification and announcement but not shareholder approval.
China BlueChemical Ltd. held its 2024 Annual General Meeting (AGM) along with class meetings for H Shareholders and Domestic Shareholders, where key resolutions were approved, including the distribution of final dividends and the appointment of new directors. The AGM saw a significant turnout with 74.73% of shares represented, highlighting strong shareholder engagement. The approval of budget proposals and re-appointment of auditors indicates a stable financial strategy moving forward, while the appointment of new directors suggests a strategic shift in leadership to enhance the company’s governance and operational efficiency.
China BlueChemical Ltd. has announced the composition of its Board of Directors, highlighting the roles and functions of each member. The board consists of executive, non-executive, and independent non-executive directors, with four committees established to oversee various aspects of the company’s governance. This announcement underscores the company’s commitment to structured governance and transparency, potentially impacting stakeholder confidence and operational oversight.
China BlueChemical Ltd. has announced a final cash dividend of RMB 0.1208 per share for the financial year ending December 31, 2024, with the payment to be made in Hong Kong dollars at a rate of HKD 0.1316 per share. This announcement reflects the company’s stable financial performance and commitment to delivering shareholder value, while also detailing the withholding tax implications for non-resident enterprise shareholders.
China BlueChemical Ltd. has announced proposed amendments to its Articles of Association, aiming to enhance corporate governance and streamline operations. The key change involves the cancellation of the supervisory committee, with its functions being transferred to the audit committee of the Board. This move aligns with recent regulatory updates and reflects the company’s commitment to improving its governance structure, potentially impacting its operational efficiency and stakeholder relations.
China BlueChemical, through its subsidiary CNOOC Jiantao, has entered into agreements with the Bank of China Hainan Branch to subscribe to structured deposit products totaling RMB450 million. These transactions, classified as discloseable under Hong Kong Listing Rules, do not require shareholder approval but necessitate notification and announcement due to the aggregated transaction amounts exceeding 5% of applicable percentage ratios.